Pharmaceuticals Ultrasector Competition

Mutual Funds . USA . 
Fund . Pharmaceuticals Ultrasector Profund
PHPIX Fund  USD 27.85  0.48  1.75%   
Pharmaceuticals Ultrasector competes with Short Real, Short Real, Ultrashort Mid-cap, Ultrashort Mid-cap, and Technology Ultrasector; as well as few others. The fund is listed under Trading--Leveraged Equity category and is part of ProFunds family. Analyzing Pharmaceuticals Ultrasector competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Pharmaceuticals Ultrasector to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Pharmaceuticals Ultrasector Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Pharmaceuticals Ultrasector competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
26.2627.8529.44
Details
Intrinsic
Valuation
LowRealHigh
26.2027.7929.38
Details

Pharmaceuticals Ultrasector Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Pharmaceuticals Ultrasector and its competitors represents the degree of relationship between the price movements of corresponding funds. A correlation of about +1.0 implies that the price of Pharmaceuticals and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Pharmaceuticals Ultrasector does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
TEPSX
+ 1.0
TEPIX
BRPSX
+ 1.0
BRPIX
BRPIX
+ 0.96
UIPSX
BRPSX
+ 0.96
UIPSX
LGPIX
+ 0.96
TEPIX
LGPIX
+ 0.96
TEPSX
  
High negative correlations   
BRPSX
- 0.99
LGPSX
BRPIX
- 0.99
LGPSX
LGPIX
- 0.93
UIPIX
LGPSX
- 0.92
UIPSX
BRPSX
- 0.85
LGPIX
BRPIX
- 0.85
LGPIX

Risk-Adjusted Indicators

There is a big difference between Pharmaceuticals Mutual Fund performing well and Pharmaceuticals Ultrasector Mutual Fund doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pharmaceuticals Ultrasector's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SRPIX  0.71 (0.04) 0.00  1.00  0.00 
 0.00 
 1.26 
(1.27)
 4.28 
SRPSX  0.69 (0.07) 0.00  10.86  0.00 
 0.00 
 1.33 
(1.32)
 4.27 
UIPIX  1.35 (0.31) 0.00  1.70  0.00 
 0.00 
 2.18 
(3.33)
 11.08 
UIPSX  1.40  0.03  0.00  0.12  0.00 
 0.00 
 2.46 
(3.32)
 13.58 
TEPIX  1.32  0.19  0.04  1.05  1.72 
(1.42)
 2.84 
(3.71)
 9.83 
TEPSX  1.32  0.19  0.04  1.02  1.72 
(1.41)
 2.81 
(3.73)
 9.85 
LGPIX  0.67  0.15  0.03  1.35  0.77 
(0.66)
 1.55 
(1.54)
 5.24 
LGPSX  0.72  0.00 (0.01) 0.13  0.96 
(0.68)
 1.55 
(2.04)
 5.23 
BRPIX  0.54  0.01  0.00  0.11  0.00 
 0.00 
 1.31 
(1.12)
 4.80 
BRPSX  0.54  0.01  0.00  0.12  0.00 
 0.00 
 1.27 
(1.09)
 4.62 
All Fundamental Data

Pharmaceuticals Ultrasector Competitive Analysis

The better you understand Pharmaceuticals Ultrasector competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Pharmaceuticals Ultrasector's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Pharmaceuticals Ultrasector's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
PHPIX SRPIX SRPSX UIPIX UIPSX TEPIX TEPSX LGPIX LGPSX BRPIX
 1.75 
 27.85 
Pharmaceuticals
 0.65 
 7.69 
Short
 0.61 
 6.55 
Short
 0.69 
 26.37 
Ultrashort
 0.71 
 22.76 
Ultrashort
 2.08 
 40.08 
Technology
 2.08 
 31.11 
TECHNOLOGY
 0.85 
 45.21 
Large
 0.87 
 34.97 
Profunds
 0.44 
 11.40 
Bear
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Not too volatile
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Modest
Very Weak
Very Weak
Very Weak
Very Weak
OK
OK
Good
Good
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Low
Low
Low
Low
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Fairly Valued
Under Valued
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Fairly Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Buy
Hold
Strong Buy
Strong Sell
Strong Sell
Cautious Hold
Cautious Hold
Hold
Strong Buy
Strong Sell
Net Asset
3.27 M
1.83 M
2.55 M
1.52 M
1.42 M
79.29 M
73.33 M
14.54 M
37.85 M
8.57 M
Minimum Initial Investment
N/A
15 K
N/A
15 K
N/A
N/A
15 K
15 K
N/A
15 K
Price To Book
2.77
N/A
N/A
N/A
N/A
3.83
3.83
4.44
4.44
N/A
Five Year Return
6.5
-8.19
-9.13
-31.78
-32.21
26.95
25.67
15.26
14.23
-14.7
One Year Return
37.63
-15.98
-16.81
-41.4
-41.63
34.82
33.43
35.65
35.58
-19.39
Last Dividend Paid
N/A
0.92
0.68
0.08
0.09
N/A
N/A
N/A
N/A
0.01
Price To Earning
6.9
N/A
N/A
N/A
N/A
2.02
1.56
22.07
22.07
N/A
Price To Sales
4.71
N/A
N/A
N/A
N/A
2.89
2.89
2.62
2.62
N/A
Cash Position Weight
19.93
100.0
105.13
84.66
126.55
19.11
23.65
N/A
0.02
85.84
Equity Positions Weight
79.98
N/A
N/A
N/A
-20.35
76.66
76.35
100.0
99.98
N/A
Three Year Return
-1.32
0.97
-0.1
-16.11
-18.2
6.14
5.07
5.25
5.31
-6.58
Annual Yield
0.0043
0.0241
0.0081
8.23
4.79
N/A
N/A
N/A
N/A
0.67
Year To Date Return
14.26
0.36
4.55
0.64
1.84
27.01
25.82
31.18
31.24
0.44
Ten Year Return
14.01
-12.89
-13.71
-27.8
-28.51
23.02
21.78
13.35
12.22
-14.66
Daily Balance Of Power
9.2 T
(9,223,372,036,855)
(9,223,372,036,855)
9.2 T
9.2 T
(9,223,372,036,855)
(9,223,372,036,855)
9.2 T
9.2 T
9.2 T
Day Typical Price
27.85
7.69
6.55
26.37
22.76
40.08
31.11
45.21
34.97
11.4
Period Momentum Indicator
0.48
(0.05)
(0.04)
0.18
0.16
(0.85)
(0.66)
0.38
0.3
0.05
Rate Of Daily Change
1.02
0.99
0.99
1.01
1.01
0.98
0.98
1.01
1.01
1.0
Day Median Price
27.85
7.69
6.55
26.37
22.76
40.08
31.11
45.21
34.97
11.4
Price Action Indicator
0.24
(0.03)
(0.02)
0.09
0.08
(0.43)
(0.33)
0.19
0.15
0.025
Coefficient Of Variation
1578.33
(2,241)
(1,544)
(582.16)
(752.50)
826.42
841.73
568.29
826.26
(907.11)
Mean Deviation
1.29
0.7085
0.6945
1.35
1.4
1.32
1.32
0.6731
0.7198
0.5443
Jensen Alpha
(0.07)
(0.04)
(0.07)
(0.31)
0.0265
0.1894
0.1851
0.1457
0.0021
0.0117
Total Risk Alpha
(0.18)
(0.20)
(0.22)
(0.64)
(0.60)
(0.1)
(0.1)
(0)
(0.06)
(0.22)
Sortino Ratio
(0.02)
N/A
N/A
N/A
N/A
0.0443
0.0422
0.0286
(0.01)
N/A
Downside Variance
2.93
N/A
N/A
N/A
N/A
3.93
3.95
1.36
1.71
N/A
Standard Deviation
1.61
0.8986
0.8852
1.86
1.97
1.86
1.86
0.9713
1.05
0.7695
Kurtosis
(0.37)
0.2681
0.4707
4.03
3.69
1.15
1.16
1.66
1.84
2.26
Potential Upside
2.61
1.26
1.33
2.18
2.46
2.84
2.81
1.55
1.55
1.31
Treynor Ratio
0.0709
0.996
10.86
1.7
0.1163
1.05
1.02
1.35
0.1299
0.1136
Maximum Drawdown
7.33
4.28
4.27
11.08
13.58
9.83
9.85
5.24
5.23
4.8
Variance
2.58
0.8075
0.7836
3.47
3.87
3.47
3.47
0.9434
1.1
0.5922
Market Risk Adjusted Performance
0.0809
1.01
10.87
1.71
0.1263
1.06
1.03
1.36
0.1399
0.1236
Risk Adjusted Performance
0.0537
(0.03)
(0.05)
(0.13)
(0.1)
0.0984
0.0967
0.1366
0.0952
(0.08)
Skewness
(0.14)
0.4821
0.5449
(1.31)
(0.80)
(0.19)
(0.19)
(0.38)
(0.67)
0.2822
Semi Deviation
1.56
N/A
N/A
N/A
N/A
1.72
1.72
0.7652
0.9629
N/A
Information Ratio
(0.02)
(0.20)
(0.22)
(0.25)
(0.20)
0.0472
0.045
0.0343
(0.01)
(0.29)
Value At Risk
(2.48)
(1.27)
(1.32)
(3.33)
(3.32)
(3.71)
(3.73)
(1.54)
(2.04)
(1.12)
Expected Short fall
(1.32)
N/A
N/A
N/A
N/A
(1.42)
(1.41)
(0.66)
(0.68)
N/A
Downside Deviation
1.71
N/A
N/A
N/A
N/A
1.98
1.99
1.17
1.31
N/A
Semi Variance
2.44
N/A
N/A
N/A
N/A
2.94
2.96
0.5855
0.9271
N/A

Pharmaceuticals Ultrasector Competition Performance Charts

Five steps to successful analysis of Pharmaceuticals Ultrasector Competition

Pharmaceuticals Ultrasector's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Pharmaceuticals Ultrasector in relation to its competition. Pharmaceuticals Ultrasector's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Pharmaceuticals Ultrasector in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Pharmaceuticals Ultrasector's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Pharmaceuticals Ultrasector, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Pharmaceuticals Ultrasector position

In addition to having Pharmaceuticals Ultrasector in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Corporate Bonds Funds Thematic Idea Now

Corporate Bonds Funds
Corporate Bonds Funds Theme
Funds or Etfs investing in different types of corporate debt instruments. The Corporate Bonds Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corporate Bonds Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Pharmaceuticals Mutual Fund

Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY